Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genotype 1 Hepatitis C Virus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01306617
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-450 With Ritonavir (ABT-450/r) When Given Together With ABT-333 and Ribavirin (RBV) in Treatment-Naïve and Non-responder Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Hepatitis C InfectionHepatitis CHepatitis C Virus
AbbVie (prior sponsor, Abbott) 50
Large-scale testing (Phase 3)Study completedNCT01704755
What this trial is testing

Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267; (ABT-267 Also Known as Ombitasvir) and ABT-333 (Also Known as Dasabuvir) Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis

Who this might be right for
Chronic Hepatitis C InfectionCompensated Cirrhosis
AbbVie (prior sponsor, Abbott) 381
Large-scale testing (Phase 3)Study completedNCT02738138
What this trial is testing

Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)

Who this might be right for
Hepatitis C Virus InfectionHuman Immunodeficiency Virus InfectionChronic Hepatitis C+1 more
AbbVie 153
Large-scale testing (Phase 3)Study completedNCT01783678
What this trial is testing

A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults

Who this might be right for
Chronic Hepatitis CHuman Immunodeficiency Virus
Gilead Sciences 275
Testing effectiveness (Phase 2)Study completedNCT01563536
What this trial is testing

Study to Assess the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of ABT-267 in HCV Infected Subjects

Who this might be right for
Chronic Hepatitis C Infection
AbbVie (prior sponsor, Abbott) 12
Testing effectiveness (Phase 2)Study completedNCT02647632
What this trial is testing

Study to Assess Efficacy and Safety of Grazoprevir/Elbasvir Associated With Sofosbuvir and Ribavirin in HCV Genotype 1 or 4-infected Patients Who Failed Direct Acting Antivirals (DAA) Bitherapy With Sofosbuvir

Who this might be right for
Hepatitis C
ANRS, Emerging Infectious Diseases 26
Not applicableStudy completedNCT02823457
What this trial is testing

VBMI to Increase Treatment Completion With MK-MK-5172/MK-8742 Among Veterans With Active Substance Use Disorders Genotype 1 Chronic Hepatitis C

Who this might be right for
Patient Adherence, Chronic Hepatitis C, Alcohol-related Disorders
G.V. (Sonny) Montgomery VA Medical Center 20
Post-approval studies (Phase 4)Study completedNCT01429792
What this trial is testing

A Study Evaluating Slow Response/Non-Rapid Response in Patients With Chronic Hepatitis C, Genotype 1, 2, 3 & 4 Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 1,013
Testing effectiveness (Phase 2)Study completedNCT01017575
What this trial is testing

Safety and Efficacy of Daclatasvir (BMS-790052) Plus Standard of Care in Japanese Patients (Pegylated-interferon Alpha-2a and Ribavirin)

Who this might be right for
Hepatitis C Infection
Bristol-Myers Squibb 55
Not applicableStudy completedNCT03341871
What this trial is testing

Glecaprevir/Pibrentasvir Drug Use Results Survey in Patients Infected With Hepatitis C Virus Genotype 1-6

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 1,095
Large-scale testing (Phase 3)Study completedNCT01846832
What this trial is testing

TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV Infection

Who this might be right for
Hepatitis C, ChronicInfection
Janssen-Cilag International NV 232
Large-scale testing (Phase 3)UnknownNCT03061032
What this trial is testing

Treatment of Hepatitis C Virus Infection With Generic Sofosbuvir/Ledipasvir in Iranian Patients

Who this might be right for
Hepatitis C
Iran Hepatitis Network 200
Post-approval studies (Phase 4)Study completedNCT00189163
What this trial is testing

Pioglitazone in Hepatitis C

Who this might be right for
Chronic Hepatitis C
University of Michigan 40
Testing effectiveness (Phase 2)Study completedNCT01995071
What this trial is testing

Evaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV)

Who this might be right for
Chronic Hepatitis CHepatitis C VirusCompensated Cirrhosis
AbbVie 89
Large-scale testing (Phase 3)Study completedNCT02170727
What this trial is testing

A Daclatasvir/Asunaprevir/BMS-791325 Fixed Dose Combination (FDC) in Subjects With Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb 199
Large-scale testing (Phase 3)Study completedNCT01471574
What this trial is testing

Safety and Efficacy Study of Daclatasvir (BMS-790052) Plus Pegylated Interferon-Alfa 2a and Ribavirin in Patients Coinfected With Untreated Hepatitis C Virus and HIV Virus

Who this might be right for
Hepatitis C, Genotype 1
Bristol-Myers Squibb 549
Post-approval studies (Phase 4)Study completedNCT00724620
What this trial is testing

PEG-IFN Alfa-2b Plus Ribavirin for Treatment of Mexican naïve Patients With Chronic Hepatitis C Infected With Genotype 1 (Study P04511)(COMPLETED)

Who this might be right for
Hepatitis C, Chronic
Schering-Plough 103
Testing effectiveness (Phase 2)Study completedNCT02868242
What this trial is testing

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer Chemotherapy

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 19
Not applicableStudy completedNCT04189627
What this trial is testing

The Effectiveness and Clinical Practice Use of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Genotypes 1 to 6 in Russian Federation

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 99
Testing effectiveness (Phase 2)Study completedNCT01011166
What this trial is testing

Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin (MK-2355-004)

Who this might be right for
Chronic Hepatitis C Infection
Merck Sharp & Dohme LLC 81
Next Page